Abstract

Losartan Potassium 2.5-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: May/Jun 2007 - Pain Management

Page(s): 248

Download in electronic PDF format for $75
  • Losartan Potassium 2.5-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Losartan Potassium 2.5-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • losartan potassium
  • high blood pressure
  • hypertension
  • angiotensin II receptor antagonist
  • angiotensin II receptor blocker
  • ARB

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2007
Pg. 248
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 326
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 232
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2017
Pg. 147
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 412
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 269
Valsartan 4-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 1999
Pg. 415-420
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Author(s): Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 61
Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 67
Potassium Chloride 2-mEq/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 237
Valsartan 16-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 139
Valsartan 4 mg/mL in Syrup NF
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292
Basics of Compounding for Iontophoresis, Part II
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 323-324
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Author(s): Quay Irene, Tan Edward
Jan/Feb 2000
Pg. 26-27
Book Review: The NMDA Receptor
Author(s): Jones Marty
Sep/Oct 2005
Pg. 339-346
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Author(s): Mishkan Emilyn S
May/Jun 2022
Pg. 234
Candesartan Cilexitil 1 mg/mL Syrup
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 302
Lisinopril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso